• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, November 16, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

AI System Screens for Major Depressive Disorder Using Routine Laboratory Tests

by
November 16, 2026
in Health
Reading Time: 2 mins read
0
AI System Screens for Major Depressive Disorder Using Routine Laboratory Tests

AI System Screens for Major Depressive Disorder Using Routine Laboratory Tests

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

An artificial intelligence-assisted screening framework called the Major Depressive Disorder Detection System, or MD3S, has been developed to identify individuals with documented major depressive disorder using routinely collected laboratory and clinical information. Reporting in Translational Psychiatry, the research team designed the computational framework to distinguish individuals diagnosed with major depressive disorder from non-depressed controls across multicenter cohorts.

Major depressive disorder represents a prevalent psychiatric condition that exerts substantial personal and societal impacts worldwide. Despite its significant health burden, the identification of affected individuals across large-scale populations continues to rely primarily on traditional symptom-based clinical assessment methods.

To construct and evaluate the screening framework in a retrospective multicenter setting, the investigators analyzed more than 180,000 real-world health assessment records drawn from the UK Biobank.

The MD3S framework operates by integrating routine hematological, biochemical, and physiological indicators captured during standard health evaluations. By analyzing these standard laboratory measurements, the model distinguishes individuals diagnosed with major depressive disorder from non-MDD control subjects.

During internal testing on the primary evaluation dataset, MD3S demonstrated strong screening capability, achieving an accuracy of 86.57 percent in classifying individuals with documented major depressive disorder and controls.

To assess whether the framework maintains cross-population generalizability beyond the initial development population, the researchers validated MD3S across two independent external hospital-based cohorts. The model maintained robust screening performance across both external clinical cohorts.

When evaluated against conventional machine learning algorithms and deep learning approaches, MD3S demonstrated improved predictive performance. The framework also exhibited stable transferability across different patient cohorts alongside high computational efficiency.

The study authors concluded that these findings highlight the potential for routine laboratory data to support scalable, artificial intelligence-assisted screening strategies. Such computational approaches could help identify individuals with major depressive disorder across diverse clinical environments and broader population settings.

Subject of Research: Artificial intelligence screening for major depressive disorder using routine clinical laboratory tests

Article Title: Artificial intelligence-assisted screening of major depressive disorder using routine laboratory tests across multicenter cohorts

Article References: Sha, Y., Pan, H., Luo, G., Meng, W., Xu, W., Feng, Z., Xing, A., Zheng, W., Zhai, X., Tong, H. H. Y., Lv, Y., Chen, X., Huang, M., & Li, K. (2026). Artificial intelligence-assisted screening of major depressive disorder using routine laboratory tests across multicenter cohorts. Translational Psychiatry. https://doi.org/10.1038/s41398-026-04413-8

Image Credits: AI Generated

DOI: 10.1038/s41398-026-04413-8

Keywords: Major Depressive Disorder, MD3S, Artificial Intelligence Screening, Routine Laboratory Tests, UK Biobank, Symptom-Based Clinical Assessment, Hematological Indicators, Biochemical Indicators, Physiological Indicators, Multicenter Cohorts, Internal Validation, External Hospital-Based Cohorts, Machine Learning, Deep Learning, Cross-Cohort Transferability, Translational Psychiatry

News Source: Blake Davidson. (November 16, 2026). AI System Screens for Major Depressive Disorder Using Routine Laboratory Tests. Scienmag.

Tags: Artificial Intelligence ScreeningBiochemical IndicatorsCross-Cohort Transferabilitydeep learningExternal Hospital-Based CohortsHematological Indicatorsinternal validationMachine Learningmajor depressive disorderMD3Smulticenter cohortsPhysiological IndicatorsRoutine Laboratory TestsSymptom-Based Clinical AssessmentTranslational PsychiatryUK Biobank
Share12Tweet7Share2ShareShareShare1

Related Posts

Virtual Reality 360-Degree Video Boosts Learning in Total Hip Arthroplasty Training

Virtual Reality 360-Degree Video Boosts Learning in Total Hip Arthroplasty Training

November 16, 2026
Vision-Language Model Screens Toddlers for Autism Using Brief Natural Play Videos

Vision-Language Model Screens Toddlers for Autism Using Brief Natural Play Videos

November 16, 2026

Ciliary CCR2 Signaling Triggers Fat Cell Formation

November 16, 2026

Autistic Brains Demonstrate Distinct Responsivity to Pharmacological Neurotransmitter Modulation

November 16, 2026

POPULAR NEWS

  • Fermented Brown Algae Postbiotic Alleviates Vascular Aging Across Multiple Animal Models

    Fermented Brown Algae Postbiotic Alleviates Vascular Aging Across Multiple Animal Models

    29 shares
    Share 12 Tweet 7
  • Myocardial Strain Imaging Detects Early Biventricular Dysfunction Across Cirrhosis Stages

    29 shares
    Share 12 Tweet 7
  • Distinct Migratory Dendritic Cells Cooperate to Prime Resident T Cells in Tumors

    29 shares
    Share 12 Tweet 7
  • Adding Ociperlimab to Tislelizumab Fails to Improve Advanced Esophageal Cancer Survival

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Pomegranate Seed Oil Reduces Renal Lipid Buildup and Fibrosis in Mice

New Statistical Model Tracks Coevolution of Online Interactions and Offline Friendships

Key Enzyme and Critical Harvest Window Drive Chachi Citrus Aroma Formation

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.